Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review

Osteoporosis leads to reduced bone mass and disrupted bone architecture. Bisphosphonates are used to treat osteoporosis by inhibiting bone resorption. Chronic bisphosphonate use has been associated with adverse effects including atypical femoral fractures (AFF). We report the case of a 63-year-old w...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Baarsel, Eric D., Patel, Vandan, Kesbeh, Yazeed, Kahf, Huthayfa, Alonzo, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735290/
https://www.ncbi.nlm.nih.gov/pubmed/31528285
http://dx.doi.org/10.1080/20009666.2019.1644894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735290/
https://www.ncbi.nlm.nih.gov/pubmed/31528285
http://dx.doi.org/10.1080/20009666.2019.1644894

Ejemplares similares